XML 46 R35.htm IDEA: XBRL DOCUMENT
v3.25.3

Share capital (Tables) | 3 Months Ended
--- | ---
Oct. 31, 2025
Share capital [Abstract] |
Share Purchase Warrants Outstanding | The continuity of share purchase warrants is as follows:
|  | Number of warrants |  |  | Weighted Average Exercise price |  |  | Remaining life (Years) |
Balance, July 31, 2024 |  |  | 132,811 |  |  | $ | 47.23 |  |  |  | 0.67 |
Issued on RTO (Note 4) |  |  | 22,699,987 |  |  | $ | 1.52 |  |  |  | - |
Exercised |  |  | (9,176 | ) |  | $ | 9.50 |  |  |  | - |
Expired |  |  | (105,032 | ) |  | $ | 56.90 |  |  |  | - |
Balance, July 31, 2025 |  |  | 22,718,590 |  |  | $ | 1.53 |  |  |  | 4.27 |
Balance, October 31, 2025 |  |  | 22,718,590 |  |  | $ | 1.53 |  |  |  | 4.02 |
As at October 31, 2025, the following share purchase warrants were outstanding:
Number of warrants outstanding |  | Exercise price |  | Expiry date |
18,603 |  | CAD$13.08 |  | September 29, 2026 |
22,699,987* |  | $1.52 |  | November 6, 2029 |
22,718,590 |  |  |  |  |
*Each warrant exercisable for 0.09692 common stock.
Stock Options Activity | The continuity of the Company’s stock options is as follows:
|  | Number of stock options |  |  | Weighted average exercise price |
Outstanding, October 31, 2024 and July 31, 2024 |  |  | 62,772 |  |  | $ | 40.20 |
Forfeited |  |  | (1,395 | ) |  | $ | 37.74 |
Granted |  |  | 50,000 |  |  | $ | 2.32 |
Cancelled |  |  | (2,733 | ) |  | $ | 37.74 |
Outstanding, July 31, 2025 |  |  | 108,644 |  |  | $ | 22.79 |
Outstanding, October 31, 2025 |  |  | 108,644 |  |  | $ | 22.50 |
Exercisable, July 31, 2025 |  |  | 51,859 |  |  | $ | 40.16 |
Exercisable, October 31, 2025 |  |  | 51,859 |  |  | $ | 39.63 |
Stock Options Outstanding and Exercisable | As at October 31, 2025, the following stock options were outstanding and exercisable:
Number of options outstanding |  | Exercise price |  | Expiry date |  | Number of options exercisable |
2,676 |  | CAD$52.40 |  | January 17, 2028 |  | 2,676 |
9,176 |  | CAD$52.40 |  | February 6, 2028 |  | 9,176 |
8,411 |  | CAD$72.60 |  | May 15, 2028 |  | 7,035 |
764 |  | CAD$77.20 |  | June 26, 2028 |  | 764 |
50,000 |  | $2.32 |  | March 26, 2030 |  | - |
22,938 |  | CAD$52.40 |  | January 17, 2032 |  | 19,500 |
4,588 |  | CAD$52.40 |  | March 1, 2032 |  | 3,900 |
917 |  | CAD$52.40 |  | March 14, 2032 |  | 780 |
7,646 |  | CAD$52.40 |  | October 12, 2032 |  | 6,500 |
1,528 |  | CAD$52.40 |  | February 6, 2033 |  | 1,528 |
108,644 |  |  |  |  |  | 51,859 |
RSUs Outstanding | The continuity of the Company’s RSU’s is as follows:
|  | Number of RSUs |
Outstanding, July 31, 2024 |  |  | 121,475 |
Granted |  |  | 30,586 |
Forfeited |  |  | (3,753 | )
Outstanding, July 31, 2025 and October 31, 2025 |  |  | 148,308 |
As at October 31, 2025, the following RSUs were outstanding and vested:
Number of RSUs outstanding |  |  | Grant date |  | Number of RSUs Vested |
| 917 |  |  | November 30, 2021 |  |  | 917 |
| 38,232 |  |  | December 24, 2021 |  |  | 32,496 |
| 1,009 |  |  | March 1, 2022 |  |  | 1,009 |
| 62,702 |  |  | March 14, 2022 |  |  | 53,985 |
| 14,862 |  |  | July 30, 2024 |  |  | 7,086 |
| 30,586 |  |  | March 26, 2025 |  |  | 25,998 |
| 148,308 |  |  |  |  |  | 121,491 |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration